Appendix B: Panel Roster and Financial Disclosures
Mpox
Member | Institution | Financial Disclosure | |
---|---|---|---|
Company | Relationship | ||
John Brooks | Atlanta, GA | None | N/A |
Chase Cannon | University of Washington | Roche Diagnostics | Consultant |
Emily Heil | University of Maryland School of Pharmacy | Wolters Kluwer | Consultant |
Jesse O’Shea* | Centers for Disease Control and Prevention | None | N/A |
Agam Rao | Centers for Disease Control and Prevention | None | N/A |
Boghuma Kabisen Titanji | Emory University School of Medicine | Critica ICMEC | Advisory Board |
GSK MEDIQ | Honoraria | ||
Critica | Consultant | ||
Jason Zucker | Columbia University Vagelos College of Physicians and Surgeons | None | N/A |
* Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
Appendix B: Panel Roster and Financial Disclosures
Mpox
Member | Institution | Financial Disclosure | |
---|---|---|---|
Company | Relationship | ||
John Brooks | Atlanta, GA | None | N/A |
Chase Cannon | University of Washington | Roche Diagnostics | Consultant |
Emily Heil | University of Maryland School of Pharmacy | Wolters Kluwer | Consultant |
Jesse O’Shea*† | Centers for Disease Control and Prevention | None | N/A |
Agam Rao† | Centers for Disease Control and Prevention | None | N/A |
Boghuma Kabisen Titanji | Emory University School of Medicine | Critica ICMEC | Advisory Board |
GSK MEDIQ | Honoraria | ||
Critica | Consultant | ||
Jason Zucker | Columbia University Vagelos College of Physicians and Surgeons | None | N/A |
* Section Group Lead † Centers for Disease Control and Prevention Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
Download Guidelines
- Section Only PDF (16.91 KB)
- Full Guideline PDF (6.03 MB)
- Tables Only PDF (1.18 MB)